Cariprazine efficacy in bipolar I depression with and without concurrent manic symptoms: post hoc analysis of 3 randomized, placebo-controlled studies.

CONCLUSION.: The results of this post hoc analysis suggest that cariprazine may be an appropriate treatment option for patients with bipolar I depression with or without manic symptoms, with higher doses potentially more effective in patients with manic symptoms. PMID: 31576791 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31576791?dopt=Abstract

Source: CNS Spectrums - October 1, 2019 Category: Neurology Authors: McIntyre RS, Suppes T, Earley W, Patel M, Stahl SM Tags: CNS Spectr Source Type: research

More News: Bipolar | Depression | Mania | Neurology | Study